115 results
Page 4 of 6
DEFA14A
37iy vciw
29 May 20
Additional proxy soliciting materials
4:11pm
8-K
EX-99
lzrfe 1w8y7hbfm
19 May 20
Cue Biopharma Reports First Quarter 2020 Results, Updates ofCUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights
4:06pm
8-K
EX-1.1
e7tzdn3bo 7b6
27 Mar 20
Entry into a Material Definitive Agreement
4:53pm
424B5
32qy7dgmuadsrmf 8s
27 Mar 20
Prospectus supplement for primary offering
4:50pm
8-K
EX-99
b48jqw3k8o2rjg6
17 Mar 20
Cue Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:23pm
S-8
1o3mmx l2s
12 Mar 20
Registration of securities for employees
5:25pm
S-8
EX-23.1
4vclrxz
12 Mar 20
Registration of securities for employees
5:25pm
8-K
EX-10.1
982dlbbof3vh6
10 Feb 20
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-1.1
0xbwp
26 Nov 19
Entry into a Material Definitive Agreement
12:00am
424B5
fy6g88ib
25 Nov 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-99
zje9yjrbh q7do932lxx
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-10.1
tpqj6m8ubc
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm
8-K
EX-10.2
u3qq5wo7
7 Oct 19
Entry into a Material Definitive Agreement
4:42pm